FREDERICK, Md., April 16, 2012 /PRNewswire/ -- BioElectronics Corporation (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced that CEO Andrew Whelan was interviewed about the Company's products, business strategy and successes by analyst Francis Gaskins.
The entire interview is available at: http://gaskinsco.com/biel-c.mp3.
In the interview, Mr. Whelan explains that pulsed short wave therapy, which has been used for decades in clinics to reduce pain, inflammation and accelerate healing, has been reduced by BIEL to a microchip that can be used safely at home 24 hours a day, making this treatment even more effective. The Company's ActiPatch products -- which can be used for back, knee, wrist, elbow and other pain, at half the cost of over-the-counter pain relievers and with no side effects – shut down the body's inflammation, push fluid out of the swollen tissue and accelerate healing, even in chronic wounds.
The interview also includes Mr. Whelan discussing the Company's patent and intellectual property protection strategy, its other products, the endorsement it received from Dr. Oz as the "new natural solution to pain," the status of clearances sought at the U.S. Food & Drug Administration, information about recent and pending scientific studies of BioElectronics' products, plus a discussion of the Company's international product distribution strategy. (The Doctor Oz video is available at http://www.doctoroz.com/videos/best-magnets-treat-your-pain.)
About BioElectronics Corporation
BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.
Contact: E & E Communications
SOURCE BioElectronics Corporation